Stage-specific miRNA signatures in osteoarthritis identify miR-4505 and miR-331-3p as key modulators of disease pathogenesis via ERBB2 suppression | Synapse
March 3, 2026
Stage-specific miRNA signatures in osteoarthritis identify miR-4505 and miR-331-3p as key modulators of disease pathogenesis via ERBB2 suppression
Key Points
Osteoarthritis is influenced by specific miRNA signatures that modulate disease processes and can identify targets for treatment.
Notably, miR-4505 and miR-331-3p play crucial roles in disease pathogenesis through the suppression of ERBB2.
Analysis of miRNA expression across different stages of osteoarthritis reveals distinct patterns linked to disease severity.
Understanding these molecular pathways may enable new strategies for therapeutics focused on miRNA modulation.